Metagil-GM1
Composition: Glimepiride 1 mg + Metformin 500 mg (Sustained Release)
Metagil GM1 is a dual-therapy anti-diabetic tablet combining Glimepiride 1 mg and Metformin SR 500 mg. This formulation offers effective control of Type 2 Diabetes by enhancing insulin secretion (Glimepiride) and reducing liver glucose output while improving insulin sensitivity (Metformin). The sustained-release form ensures smoother sugar control throughout the day with fewer gastric side effects. Metagil GM1 is ideal for patients not adequately controlled on Metformin alone.
Uses:
- Management of Type 2 Diabetes Mellitus
- Controls fasting and post-meal sugar
- Helps reduce HbA1c levels
- Suitable as combination therapy
Side Effects:
- Hypoglycemia
- Dizziness, sweating
- Stomach upset or diarrhea
- Weight gain (mild)
- Rare: lactic acidosis
Other Details:
- Take before or with meals
- Do not skip meals to avoid low sugar
- Not recommended in severe kidney or liver issues
